Why We Walk

Faster diagnosis. Improved treatments. Revolutionary research. These breakthroughs in care and knowledge about pediatric inflammatory bowel disease (IBD) at Children’s Hospital of Philadelphia are creating new hope for children who have this painful and often debilitating disease.

IBD patient William with nurse

Exceptional Patient Care and Treatment

Inflammatory bowel disease — which refers to both Crohn’s disease and ulcerative colitis — is the fastest-growing autoimmune disorder in children younger than 5. Each year, the Center for Pediatric Inflammatory Bowel Disease at CHOP treats more than 1,800 young patients who suffer from abdominal pain, intestinal inflammation and other symptoms.

lab technician

Breakthrough Research

The past few years have produced an explosion of knowledge about the genetics of IBD and expanded treatment options. Today, expert gastroenterologists, geneticists, and researchers work together to evaluate each child’s DNA and microbiome with the goal of developing true personalized medicine. Please join us in our journey toward a cure for all children with IBD.

Want a closer look at what your dollars are funding? Follow CHOP researchers Melissa and Corey as they share a behind-the-scenes look at their work on the Biorepository Study – one of many research projects funded by Walk for Hope!


Our Ambassadors

EmmyPatient Ambassadors for Walk for Hope have a big job to do. It’s up to them to represent the millions of children living with inflammatory bowel disease. As they share their stories, they help the world understand the toll that IBD takes and why it’s worth supporting institutions like Children’s Hospital of Philadelphia.

Meet Our Ambassadors


is the fastest-growing autoimmune disorder in children younger than 5.
Donations to Walk for Hope Virtual Edition benefit children afflicted with IBD in our community and around the world.